Recognition - Sequel Legal

Recognition

Sequel attorneys have proven experience and a reputation for thoughtful leadership in their focused areas of practice.

Our attorneys provide education and analysis on timely issues through scholarly publications, national conferences, and the news media.

Sequel’s attorneys, advisors, and law clerks have published the following peer-reviewed, scholarly articles:

Lynn Webster, Olivia Backhaus, and Amy Bianco, T hree Recent Court Decisions Reframe What Constitutes Criminal Conduct in Prescribing Controlled Substances, 19 J. of Opioid Manag. 17-21 (2023).
Michael C. Barnes, et al., Demanding Better: A Case for Increased Funding and Involvement of State Medical Boards in Response to America’s Drug Abuse Crisis, 106(3) J. Med. Reg. 6 (2020).

Michael C. Barnes & Daniel C. McClughen, Warm Handoffs: The Duty of and Legal Issues Surrounding Emergency Departments in Reducing the Risk of Subsequent Drug Overdoses, 48 U. Mem. L. Rev. 1100 (2019).

Michael C. Barnes, et al., Potential Impact of Texas et al v United States on Persons with Substance Use Disorder, ABA Health eSource (Oct. 2018).

Michael C. Barnes, Diligence and Documentation: Managing the Risks of Prescribing Controlled Substances, 5 PainWeek J. 52 (2017).

Stacey L. Worthy, et al., The Compounding Conundrum: How Insufficient Delineation of Regulatory Responsibility Has Created a Need for State and Federal Compounding Drug Law Reform, 72(3) Food & Drug L.J. (2017).

Stacey L. Worthy, et al., Now or Never: The Urgent Need for Action Against Unfair Coverage Denials for Quality Health Care, 48 Loy. U. Chi. L.J. 1041 (2017).

Gary Branning & Stacey L. Worthy, Emphasize Shared Decision-Making Between Physicians & Patients to Improve Diabetes Outcomes, 10 Am. Health & Drug Benefit J. 242 (2017).

Daniel C. McClughen & Marsha Stanton, The CDC Guideline and its Impact on Delivering Patient-Centered Care, 18 Pain Mgmt. Nursing 5 (2017).

Shruti R. Kulkarni, et al., What’s in a number? Recommending practicality in the DATA 2000 patient limits, 12(4) J. Opioid Mgmt. 243 (2016).

Michael C. Barnes, et al., A Call for Differential Diagnosis of Non-Specific Low Back Pain to Reduce Opioid Abuse, 101 J. Med. Reg. 39 (2015).

Michael C. Barnes & Stacey L. Worthy, Evaluating Motives: Two Simple Tests to Identify and Avoid Entanglement in Legally Dubious Urine Drug Testing Schemes, 11 J. Opioid Mgmt. 89 (2015).

Michael C. Barnes, et al.,  Abuse-Deterrent Formulations: Transitioning the Pharmaceutical Market to Improve Public Health and Safety, 6 Therapeutic Advances in Drug Safety 1 (2015).

Michael C. Barnes & Stacey L. Worthy, Achieving Real Parity: Increasing Access to Treatment for Substance Use Disorders Under the Patient Protection and Affordable Care Act and the Mental Health and Addiction Equity Act, 36 U Ark Little Rock L. Rev. 555 (2015).

Michael C. Barnes & Stacey L. Sklaver, Applying Lessons from the Opioid Abuse Epidemic to Protect Consumers from Gray Market Biologics, 29 Notre Dame J.L. Ethics & Pub. Pol’y 375 (2015).

Michael C. Barnes & Stacey L. Sklaver, Active Verification and Vigilance: A Method To Avoid Civil and Criminal Liability When Prescribing Controlled Substances, 15 DePaul J. Health Care L. 93 (2013).

Michael C. Barnes & Gretchen Arndt, The Best of Both Worlds: Applying Federal Commerce and State Police Powers To Reduce Prescription Drug Abuse, 16 J. Health Care L. & Pol’y 271 (2013).

Michael C. Barnes, et al., A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 1 & Part 2, 3(4) J. Global Drug Pol’y & Prac. (2009).

Sequel’s technology & IP professionals have published the following peer-reviewed, scholarly articles:

Paula J. Bruening & Mary J. Culnan, Through a Glass Darkly: From Privacy Notices to Effective Transparency, 17 N.C. J.L. & TECH. 515 (2016).

David Hoffman, Paula Bruening & Sophia Carter, The Right to Obscurity: How We Can Implement the Google Spain Decision, 17 N.C. J.L. & TECH. 437 (2016).

GK. Krasnow Waterman & Paula J. Bruening, Big Data Analytics: Risk and Responsibilities, 4 INT’L DATA PRIVACY L. 89 (2014).

Paula J. Breuning & K. Krasnow Waterman, Data Tagging for New Information Governance Models, 8.5 IEEE SECURITY & PRIVACY MAG. 64 (2010).

Paula J. Bruening, Accountability: Part of the International Public Dialogue About Privacy Governance, 10 BNA Int’l 1 (2010).

Paula J. Bruening & Bridget C. Treacy, Cloud Computing: Privacy, Security Challenges, 8 BNA, INC. PRIVACY & SECURITY LAW REP. 1 (2009).

Paula J. Breuning & Bridget Treacy, Cloud Computing — Data Protection Concerns Unwrapped, 3(4) J. Global Drug Pol’y & Prac. (2009).

Our attorneys have presented at the following conferences, among many others:

American Academy of Pain Medicine
Addiction Executives Industry Summit
American Society of Addiction Medicine
American Society of Plastic Surgeons
The Economist: War on Cancer
FDA/CMS Summit
International Conference on Opioids
National Association of Attorneys General
National Association of State Controlled Substances Authorities
National Conference of State Legislatures
National Sheriffs’ Association
Providers’ Clinical Support System
Rx Drug Abuse & Heroin Summit

For a full listing of our attorneys’ speaking engagements, view our bios.

Our attorneys and advisors have provided thought leadership and analysis to news organizations including:

Alcohol & Drug Abuse Weekly
Associated Press
Behavioral Healthcare Executive
Bloomberg
Bustle
BuzzFeed
CBS News
CNBC
CNN
FDA Week
FierceHealthcare
Filter
FOX Business
FOX News
Inc. Magazine

InsideHealthPolicy
HLN
Morning Consult
MSNBC
Newsweek
The Hill
The New Yorker
The New York Times
RealClearHealth
Reuters
Time Magazine
Tonic
Vox
The Wall Street Journal
WebMD